

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle fiber development (GO:0048741) | 9.53943805 |
| 2 | muscle cell fate commitment (GO:0042693) | 9.38399552 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.04808629 |
| 4 | actin-mediated cell contraction (GO:0070252) | 8.84557695 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 8.52757215 |
| 6 | myotube cell development (GO:0014904) | 8.24134617 |
| 7 | positive regulation of myotube differentiation (GO:0010831) | 7.24982479 |
| 8 | myotube differentiation (GO:0014902) | 6.65971474 |
| 9 | striated muscle contraction (GO:0006941) | 6.65925785 |
| 10 | response to inactivity (GO:0014854) | 6.64576706 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.53988890 |
| 12 | dopamine biosynthetic process (GO:0042416) | 6.41644381 |
| 13 | alkaloid metabolic process (GO:0009820) | 6.37670933 |
| 14 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.37282290 |
| 15 | actin filament-based movement (GO:0030048) | 6.33963644 |
| 16 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 6.19958157 |
| 17 | * lens development in camera-type eye (GO:0002088) | 6.14820703 |
| 18 | creatine metabolic process (GO:0006600) | 6.07081062 |
| 19 | muscle fiber development (GO:0048747) | 5.76645684 |
| 20 | myofibril assembly (GO:0030239) | 5.63412884 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 5.49603746 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.49603746 |
| 23 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 5.48476935 |
| 24 | lens fiber cell development (GO:0070307) | 5.48332272 |
| 25 | sarcomere organization (GO:0045214) | 5.46805876 |
| 26 | regulation of relaxation of muscle (GO:1901077) | 5.36645440 |
| 27 | muscle contraction (GO:0006936) | 5.15673192 |
| 28 | plasma membrane repair (GO:0001778) | 5.09034086 |
| 29 | dopamine transport (GO:0015872) | 5.08120868 |
| 30 | bile acid and bile salt transport (GO:0015721) | 5.07994966 |
| 31 | skeletal muscle tissue development (GO:0007519) | 5.06441785 |
| 32 | nucleobase catabolic process (GO:0046113) | 5.02085565 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 5.00870732 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.00870732 |
| 35 | aromatic amino acid family catabolic process (GO:0009074) | 4.94294261 |
| 36 | striated muscle atrophy (GO:0014891) | 4.94182849 |
| 37 | bile acid biosynthetic process (GO:0006699) | 4.73503204 |
| 38 | cytolysis (GO:0019835) | 4.70454599 |
| 39 | regulation of somitogenesis (GO:0014807) | 4.68990168 |
| 40 | glyoxylate metabolic process (GO:0046487) | 4.68314277 |
| 41 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.67406328 |
| 42 | kynurenine metabolic process (GO:0070189) | 4.63878003 |
| 43 | muscle atrophy (GO:0014889) | 4.62739838 |
| 44 | muscle system process (GO:0003012) | 4.61319728 |
| 45 | indolalkylamine metabolic process (GO:0006586) | 4.57422741 |
| 46 | cardiac muscle contraction (GO:0060048) | 4.56664063 |
| 47 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.55569150 |
| 48 | response to insecticide (GO:0017085) | 4.54766718 |
| 49 | ethanol oxidation (GO:0006069) | 4.53806371 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.52988095 |
| 51 | urea cycle (GO:0000050) | 4.52822413 |
| 52 | urea metabolic process (GO:0019627) | 4.52822413 |
| 53 | glycogen biosynthetic process (GO:0005978) | 4.47520153 |
| 54 | glucan biosynthetic process (GO:0009250) | 4.47520153 |
| 55 | indole-containing compound catabolic process (GO:0042436) | 4.47152415 |
| 56 | indolalkylamine catabolic process (GO:0046218) | 4.47152415 |
| 57 | tryptophan catabolic process (GO:0006569) | 4.47152415 |
| 58 | skeletal muscle adaptation (GO:0043501) | 4.43298988 |
| 59 | striated muscle cell development (GO:0055002) | 4.37672828 |
| 60 | * dopaminergic neuron differentiation (GO:0071542) | 4.33513371 |
| 61 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.32345492 |
| 62 | alpha-linolenic acid metabolic process (GO:0036109) | 4.29306331 |
| 63 | complement activation, alternative pathway (GO:0006957) | 4.28271279 |
| 64 | cardiac myofibril assembly (GO:0055003) | 4.26219725 |
| 65 | nitrogen cycle metabolic process (GO:0071941) | 4.25873015 |
| 66 | neuromuscular synaptic transmission (GO:0007274) | 4.20709393 |
| 67 | tyrosine metabolic process (GO:0006570) | 4.20226347 |
| 68 | muscle organ development (GO:0007517) | 4.17335946 |
| 69 | muscle structure development (GO:0061061) | 4.13094334 |
| 70 | glycogen catabolic process (GO:0005980) | 4.11643342 |
| 71 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 4.05604243 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 4.02886950 |
| 73 | muscle organ morphogenesis (GO:0048644) | 4.00284492 |
| 74 | regulation of protein activation cascade (GO:2000257) | 3.98975877 |
| 75 | tryptophan metabolic process (GO:0006568) | 3.98793629 |
| 76 | skeletal muscle tissue regeneration (GO:0043403) | 3.98275108 |
| 77 | regulation of fibrinolysis (GO:0051917) | 3.97961352 |
| 78 | actomyosin structure organization (GO:0031032) | 3.97862475 |
| 79 | striated muscle adaptation (GO:0014888) | 3.96327672 |
| 80 | catecholamine biosynthetic process (GO:0042423) | 3.90574103 |
| 81 | catechol-containing compound biosynthetic process (GO:0009713) | 3.90574103 |
| 82 | acetyl-CoA metabolic process (GO:0006084) | 3.90258467 |
| 83 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.87886028 |
| 84 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.87336744 |
| 85 | negative regulation of microtubule polymerization (GO:0031115) | 3.84228197 |
| 86 | muscle cell development (GO:0055001) | 3.83583218 |
| 87 | cellular ketone body metabolic process (GO:0046950) | 3.83473483 |
| 88 | glucan catabolic process (GO:0009251) | 3.81852132 |
| 89 | muscle cell cellular homeostasis (GO:0046716) | 3.78739804 |
| 90 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.78011467 |
| 91 | bile acid metabolic process (GO:0008206) | 3.75929455 |
| 92 | regulation of complement activation (GO:0030449) | 3.74897048 |
| 93 | regulation of actin filament-based movement (GO:1903115) | 3.74388639 |
| 94 | aromatic amino acid family metabolic process (GO:0009072) | 3.73308048 |
| 95 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.67774090 |
| 96 | sulfur amino acid catabolic process (GO:0000098) | 3.66412887 |
| 97 | regulation of myotube differentiation (GO:0010830) | 3.62531020 |
| 98 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.62482858 |
| 99 | regulation of dopamine metabolic process (GO:0042053) | 3.60955944 |
| 100 | regulation of catecholamine metabolic process (GO:0042069) | 3.60955944 |
| 101 | muscle tissue morphogenesis (GO:0060415) | 3.56864333 |
| 102 | catecholamine transport (GO:0051937) | 3.56626980 |
| 103 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.55895369 |
| 104 | response to activity (GO:0014823) | 3.55501506 |
| 105 | cysteine metabolic process (GO:0006534) | 3.55091605 |
| 106 | protein carboxylation (GO:0018214) | 3.51481255 |
| 107 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.51481255 |
| 108 | serine family amino acid catabolic process (GO:0009071) | 3.50729937 |
| 109 | positive regulation of myoblast differentiation (GO:0045663) | 3.50690061 |
| 110 | striated muscle tissue development (GO:0014706) | 3.50410508 |
| 111 | myoblast fusion (GO:0007520) | 3.50248177 |
| 112 | cellular polysaccharide catabolic process (GO:0044247) | 3.49394010 |
| 113 | fatty acid elongation (GO:0030497) | 3.45725736 |
| 114 | dorsal/ventral neural tube patterning (GO:0021904) | 3.44861717 |
| 115 | positive regulation of striated muscle cell differentiation (GO:0051155) | 3.42808679 |
| 116 | imidazole-containing compound metabolic process (GO:0052803) | 3.41944440 |
| 117 | regulation of cell communication by electrical coupling (GO:0010649) | 3.41692359 |
| 118 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.41669712 |
| 119 | homocysteine metabolic process (GO:0050667) | 3.39576637 |
| 120 | positive regulation of skeletal muscle tissue development (GO:0048643) | 3.36549013 |
| 121 | regulation of striated muscle contraction (GO:0006942) | 3.32992804 |
| 122 | alpha-amino acid catabolic process (GO:1901606) | 3.32747799 |
| 123 | aldehyde catabolic process (GO:0046185) | 3.32389652 |
| 124 | indole-containing compound metabolic process (GO:0042430) | 3.29179559 |
| 125 | NADH metabolic process (GO:0006734) | 3.29058631 |
| 126 | glutamate metabolic process (GO:0006536) | 3.28655521 |
| 127 | ketone body metabolic process (GO:1902224) | 3.27030661 |
| 128 | high-density lipoprotein particle remodeling (GO:0034375) | 3.26985699 |
| 129 | glycogen metabolic process (GO:0005977) | 3.26498627 |
| 130 | arginine metabolic process (GO:0006525) | 3.26172608 |
| 131 | lysine catabolic process (GO:0006554) | 3.24069403 |
| 132 | lysine metabolic process (GO:0006553) | 3.24069403 |
| 133 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.23828647 |
| 134 | acylglycerol homeostasis (GO:0055090) | 3.22344455 |
| 135 | triglyceride homeostasis (GO:0070328) | 3.22344455 |
| 136 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.21016932 |
| 137 | benzene-containing compound metabolic process (GO:0042537) | 3.20653546 |
| 138 | glucan metabolic process (GO:0044042) | 3.18483822 |
| 139 | cellular glucan metabolic process (GO:0006073) | 3.18483822 |
| 140 | regulation of myoblast differentiation (GO:0045661) | 3.17026442 |
| 141 | neurotransmitter biosynthetic process (GO:0042136) | 3.16795354 |
| 142 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.15927177 |
| 143 | response to muscle activity (GO:0014850) | 3.15297416 |
| 144 | muscle adaptation (GO:0043500) | 3.14406855 |
| 145 | regulation of triglyceride catabolic process (GO:0010896) | 3.13978631 |
| 146 | polysaccharide catabolic process (GO:0000272) | 3.13279295 |
| 147 | cellular biogenic amine catabolic process (GO:0042402) | 3.11290212 |
| 148 | amine catabolic process (GO:0009310) | 3.11290212 |
| 149 | cardiac muscle cell development (GO:0055013) | 3.10719233 |
| 150 | cellular amino acid catabolic process (GO:0009063) | 3.08703079 |
| 151 | cellular response to estradiol stimulus (GO:0071392) | 3.07077251 |
| 152 | muscle tissue development (GO:0060537) | 3.06049004 |
| 153 | ethanol metabolic process (GO:0006067) | 3.05581785 |
| 154 | cardiac muscle hypertrophy (GO:0003300) | 3.04629714 |
| 155 | ubiquinone biosynthetic process (GO:0006744) | 3.04213192 |
| 156 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.04136697 |
| 157 | cellular modified amino acid catabolic process (GO:0042219) | 3.03684554 |
| 158 | regulation of plasminogen activation (GO:0010755) | 3.02260265 |
| 159 | fatty acid transmembrane transport (GO:1902001) | 2.98554626 |
| 160 | amino-acid betaine metabolic process (GO:0006577) | 2.98546467 |
| 161 | cofactor catabolic process (GO:0051187) | 2.95957018 |
| 162 | midgut development (GO:0007494) | 2.95503902 |
| 163 | plasma lipoprotein particle remodeling (GO:0034369) | 2.93923012 |
| 164 | protein-lipid complex remodeling (GO:0034368) | 2.93923012 |
| 165 | macromolecular complex remodeling (GO:0034367) | 2.93923012 |
| 166 | gluconeogenesis (GO:0006094) | 2.93649709 |
| 167 | skeletal muscle cell differentiation (GO:0035914) | 2.93162097 |
| 168 | regulation of dopamine secretion (GO:0014059) | 2.92793436 |
| 169 | IMP metabolic process (GO:0046040) | 2.92757842 |
| 170 | striated muscle hypertrophy (GO:0014897) | 2.91177495 |
| 171 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.89019036 |
| 172 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.89019036 |
| 173 | neuron cell-cell adhesion (GO:0007158) | 2.88896521 |
| 174 | carnitine shuttle (GO:0006853) | 2.88469861 |
| 175 | phospholipid efflux (GO:0033700) | 2.87207972 |
| 176 | positive regulation of muscle cell differentiation (GO:0051149) | 2.85160704 |
| 177 | linoleic acid metabolic process (GO:0043651) | 2.85096894 |
| 178 | mating behavior (GO:0007617) | 2.84113200 |
| 179 | glycine metabolic process (GO:0006544) | 2.83495384 |
| 180 | 2-oxoglutarate metabolic process (GO:0006103) | 2.83024763 |
| 181 | cardiac cell development (GO:0055006) | 2.81160348 |
| 182 | adult heart development (GO:0007512) | 2.81133493 |
| 183 | regulation of sequestering of triglyceride (GO:0010889) | 2.80416755 |
| 184 | response to cocaine (GO:0042220) | 2.79603086 |
| 185 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.78463665 |
| 186 | regulation of cardioblast proliferation (GO:0003264) | 2.78463665 |
| 187 | very long-chain fatty acid metabolic process (GO:0000038) | 2.76797481 |
| 188 | regulation of bile acid biosynthetic process (GO:0070857) | 2.76406752 |
| 189 | ubiquinone metabolic process (GO:0006743) | 2.73689428 |
| 190 | negative regulation of muscle contraction (GO:0045932) | 2.73165553 |
| 191 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.67937076 |
| 192 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.67937076 |
| 193 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.67740159 |
| 194 | kidney mesenchyme development (GO:0072074) | 2.67090356 |
| 195 | oxidative phosphorylation (GO:0006119) | 2.65380675 |
| 196 | muscle filament sliding (GO:0030049) | 10.8191907 |
| 197 | actin-myosin filament sliding (GO:0033275) | 10.8191907 |
| 198 | skeletal muscle contraction (GO:0003009) | 10.1530122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.29353712 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.05835286 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.67820503 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.44463463 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.37927098 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.34284465 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17916186 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.12157149 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.02288212 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.91884088 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.55360014 |
| 12 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.27316408 |
| 13 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.22956822 |
| 14 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.22149944 |
| 15 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20075306 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17744260 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.17533828 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.15284354 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.07155303 |
| 20 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05111984 |
| 21 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02005767 |
| 22 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02005767 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01225180 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97446198 |
| 25 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.91227097 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90526893 |
| 27 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.89390024 |
| 28 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86260668 |
| 29 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.82247210 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.82161516 |
| 31 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81641354 |
| 32 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80424274 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.79731575 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.79137231 |
| 35 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78034047 |
| 36 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.76895478 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74278337 |
| 38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.74075532 |
| 39 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.72745227 |
| 40 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.72745227 |
| 41 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.69782474 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.66264660 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.64714843 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.63399227 |
| 45 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.62469539 |
| 46 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.60876672 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60576158 |
| 48 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59956319 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59013809 |
| 50 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.58933745 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53842452 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49217527 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49166226 |
| 54 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48617451 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44366956 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44128168 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43158752 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40559239 |
| 59 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40030114 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39613446 |
| 61 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.37671741 |
| 62 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.36276282 |
| 63 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.36152546 |
| 64 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.30875544 |
| 65 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30580487 |
| 66 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29966321 |
| 67 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.28810715 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27753806 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24826126 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24179360 |
| 71 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23981512 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23583776 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.23324923 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22590071 |
| 75 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19619886 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19012949 |
| 77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17691662 |
| 78 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16569145 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16340002 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16180681 |
| 81 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16063655 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15480120 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15442098 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14984430 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14827352 |
| 86 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.13211260 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.11841444 |
| 88 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11454954 |
| 89 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10968361 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10656107 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10466887 |
| 92 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10462233 |
| 93 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.08486581 |
| 94 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07710840 |
| 95 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.07665466 |
| 96 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.06668637 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06269267 |
| 98 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05790918 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05468123 |
| 100 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04669369 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04410703 |
| 102 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04292627 |
| 103 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.03548870 |
| 104 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02600991 |
| 105 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00961455 |
| 106 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00603744 |
| 107 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00031223 |
| 108 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98760679 |
| 109 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98760679 |
| 110 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96479708 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96337363 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96196338 |
| 113 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95598546 |
| 114 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94897315 |
| 115 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94508998 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93410331 |
| 117 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93051292 |
| 118 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92349002 |
| 119 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.91661010 |
| 120 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.91387169 |
| 121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91053066 |
| 122 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.90962912 |
| 123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89448260 |
| 124 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88719208 |
| 125 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88679167 |
| 126 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87901404 |
| 127 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87175547 |
| 128 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86893963 |
| 129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86591016 |
| 130 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86469000 |
| 131 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86251263 |
| 132 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.83649377 |
| 133 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83465455 |
| 134 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.83437340 |
| 135 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82914059 |
| 136 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82215519 |
| 137 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81235527 |
| 138 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80900910 |
| 139 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80795621 |
| 140 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.80146986 |
| 141 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.80146986 |
| 142 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.79573478 |
| 143 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.78624672 |
| 144 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.78179513 |
| 145 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77071494 |
| 146 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76300876 |
| 147 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.75996044 |
| 148 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74723284 |
| 149 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73935100 |
| 150 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72403819 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.71513631 |
| 152 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.71097852 |
| 153 | P300_19829295_ChIP-Seq_ESCs_Human | 0.70923420 |
| 154 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.70792083 |
| 155 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68806468 |
| 156 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.67595872 |
| 157 | KDM2B_26808549_Chip-Seq_K562_Human | 0.66601968 |
| 158 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65905532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.19387343 |
| 2 | MP0000569_abnormal_digit_pigmentation | 5.46313700 |
| 3 | MP0005360_urolithiasis | 4.53343907 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.31324438 |
| 5 | MP0005365_abnormal_bile_salt | 3.88756736 |
| 6 | MP0000733_abnormal_muscle_development | 3.79275788 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.58844703 |
| 8 | * MP0002697_abnormal_eye_size | 3.18301856 |
| 9 | MP0004233_abnormal_muscle_weight | 3.08989710 |
| 10 | MP0003252_abnormal_bile_duct | 2.80939991 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.70447633 |
| 12 | MP0005083_abnormal_biliary_tract | 2.61660610 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.57283625 |
| 14 | MP0006276_abnormal_autonomic_nervous | 2.44887225 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.44148257 |
| 16 | MP0009379_abnormal_foot_pigmentation | 2.43748828 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.43372074 |
| 18 | * MP0001905_abnormal_dopamine_level | 2.33034008 |
| 19 | MP0000751_myopathy | 2.24125776 |
| 20 | MP0003880_abnormal_central_pattern | 2.07256309 |
| 21 | * MP0005193_abnormal_anterior_eye | 1.97410392 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.95831826 |
| 23 | MP0000749_muscle_degeneration | 1.95623723 |
| 24 | MP0003283_abnormal_digestive_organ | 1.92942865 |
| 25 | MP0000566_synostosis | 1.86754793 |
| 26 | MP0003868_abnormal_feces_composition | 1.77823449 |
| 27 | MP0004215_abnormal_myocardial_fiber | 1.68398600 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.66067108 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.63519666 |
| 30 | MP0006035_abnormal_mitochondrial_morpho | 1.59114720 |
| 31 | MP0005220_abnormal_exocrine_pancreas | 1.57760302 |
| 32 | MP0005670_abnormal_white_adipose | 1.56121024 |
| 33 | MP0010030_abnormal_orbit_morphology | 1.55558903 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.52874357 |
| 35 | MP0000747_muscle_weakness | 1.35896791 |
| 36 | MP0005332_abnormal_amino_acid | 1.34663650 |
| 37 | MP0004270_analgesia | 1.32709804 |
| 38 | MP0003195_calcinosis | 1.31687066 |
| 39 | MP0010630_abnormal_cardiac_muscle | 1.28627707 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.27703439 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.27524758 |
| 42 | MP0004145_abnormal_muscle_electrophysio | 1.27004435 |
| 43 | MP0001529_abnormal_vocalization | 1.25582650 |
| 44 | MP0003137_abnormal_impulse_conducting | 1.23266434 |
| 45 | MP0002127_abnormal_cardiovascular_syste | 1.22315111 |
| 46 | MP0004185_abnormal_adipocyte_glucose | 1.20851924 |
| 47 | MP0002269_muscular_atrophy | 1.20477684 |
| 48 | * MP0002118_abnormal_lipid_homeostasis | 1.20329525 |
| 49 | MP0002108_abnormal_muscle_morphology | 1.20251187 |
| 50 | MP0004859_abnormal_synaptic_plasticity | 1.19099175 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.16584497 |
| 52 | MP0006138_congestive_heart_failure | 1.15836955 |
| 53 | MP0002184_abnormal_innervation | 1.09645109 |
| 54 | MP0000778_abnormal_nervous_system | 1.07983872 |
| 55 | * MP0000609_abnormal_liver_physiology | 1.06967471 |
| 56 | MP0005409_darkened_coat_color | 1.06173139 |
| 57 | MP0003942_abnormal_urinary_system | 1.04800621 |
| 58 | MP0001661_extended_life_span | 1.03310837 |
| 59 | * MP0005197_abnormal_uvea_morphology | 1.03241468 |
| 60 | MP0003136_yellow_coat_color | 1.02516246 |
| 61 | MP0004858_abnormal_nervous_system | 1.02489321 |
| 62 | MP0003635_abnormal_synaptic_transmissio | 1.00888958 |
| 63 | MP0000759_abnormal_skeletal_muscle | 0.99214714 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.97800570 |
| 65 | * MP0005535_abnormal_body_temperature | 0.96584218 |
| 66 | MP0005666_abnormal_adipose_tissue | 0.95498512 |
| 67 | MP0003879_abnormal_hair_cell | 0.95312292 |
| 68 | MP0005385_cardiovascular_system_phenoty | 0.95258757 |
| 69 | MP0001544_abnormal_cardiovascular_syste | 0.95258757 |
| 70 | MP0000579_abnormal_nail_morphology | 0.94161181 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.92874267 |
| 72 | MP0005375_adipose_tissue_phenotype | 0.92402292 |
| 73 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91504217 |
| 74 | MP0005187_abnormal_penis_morphology | 0.90919915 |
| 75 | MP0002638_abnormal_pupillary_reflex | 0.89676140 |
| 76 | MP0004484_altered_response_of | 0.89623893 |
| 77 | MP0005248_abnormal_Harderian_gland | 0.88989571 |
| 78 | MP0004019_abnormal_vitamin_homeostasis | 0.88977083 |
| 79 | MP0005369_muscle_phenotype | 0.88940029 |
| 80 | MP0002090_abnormal_vision | 0.88591893 |
| 81 | MP0004087_abnormal_muscle_fiber | 0.88173606 |
| 82 | MP0000538_abnormal_urinary_bladder | 0.85761005 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.85381970 |
| 84 | MP0005423_abnormal_somatic_nervous | 0.85184474 |
| 85 | MP0004883_abnormal_blood_vessel | 0.85044179 |
| 86 | MP0009840_abnormal_foam_cell | 0.84385304 |
| 87 | MP0009250_abnormal_appendicular_skeleto | 0.83478148 |
| 88 | MP0004130_abnormal_muscle_cell | 0.81979774 |
| 89 | MP0005266_abnormal_metabolism | 0.80795670 |
| 90 | * MP0005319_abnormal_enzyme/_coenzyme | 0.80416381 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.79745351 |
| 92 | MP0002106_abnormal_muscle_physiology | 0.79211720 |
| 93 | MP0009053_abnormal_anal_canal | 0.78705442 |
| 94 | MP0002163_abnormal_gland_morphology | 0.77183053 |
| 95 | MP0005253_abnormal_eye_physiology | 0.76826753 |
| 96 | MP0004924_abnormal_behavior | 0.76790764 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.76790764 |
| 98 | MP0003705_abnormal_hypodermis_morpholog | 0.76683198 |
| 99 | MP0002971_abnormal_brown_adipose | 0.75494940 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.75208549 |
| 101 | MP0000750_abnormal_muscle_regeneration | 0.74876987 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74316918 |
| 103 | MP0006036_abnormal_mitochondrial_physio | 0.73870601 |
| 104 | MP0002067_abnormal_sensory_capabilities | 0.73150050 |
| 105 | MP0005620_abnormal_muscle_contractility | 0.72253810 |
| 106 | * MP0001286_abnormal_eye_development | 0.72110202 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.71993006 |
| 108 | MP0002822_catalepsy | 0.71150587 |
| 109 | MP0000762_abnormal_tongue_morphology | 0.68923956 |
| 110 | MP0002114_abnormal_axial_skeleton | 0.68875978 |
| 111 | MP0003950_abnormal_plasma_membrane | 0.68628686 |
| 112 | MP0001188_hyperpigmentation | 0.67202274 |
| 113 | MP0000049_abnormal_middle_ear | 0.66696554 |
| 114 | * MP0003959_abnormal_lean_body | 0.66008659 |
| 115 | MP0000462_abnormal_digestive_system | 0.65461576 |
| 116 | MP0005330_cardiomyopathy | 0.65005101 |
| 117 | MP0002751_abnormal_autonomic_nervous | 0.64059265 |
| 118 | MP0002177_abnormal_outer_ear | 0.63807244 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.63047406 |
| 120 | * MP0002063_abnormal_learning/memory/cond | 0.62755782 |
| 121 | MP0001440_abnormal_grooming_behavior | 0.60432415 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.59960751 |
| 123 | MP0003646_muscle_fatigue | 0.58975456 |
| 124 | MP0003123_paternal_imprinting | 0.57563781 |
| 125 | MP0005451_abnormal_body_composition | 0.55534173 |
| 126 | MP0002064_seizures | 0.55045906 |
| 127 | MP0002932_abnormal_joint_morphology | 0.54943289 |
| 128 | MP0003122_maternal_imprinting | 0.54764135 |
| 129 | * MP0002066_abnormal_motor_capabilities/c | 0.54344094 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.54171936 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.53964100 |
| 132 | * MP0002572_abnormal_emotion/affect_behav | 0.53661174 |
| 133 | MP0001486_abnormal_startle_reflex | 0.53198636 |
| 134 | MP0000678_abnormal_parathyroid_gland | 0.53089465 |
| 135 | MP0004134_abnormal_chest_morphology | 0.53063013 |
| 136 | MP0004142_abnormal_muscle_tone | 0.52989065 |
| 137 | MP0004085_abnormal_heartbeat | 0.52527240 |
| 138 | MP0002796_impaired_skin_barrier | 0.52422327 |
| 139 | MP0004510_myositis | 0.52059528 |
| 140 | * MP0001340_abnormal_eyelid_morphology | 0.51841692 |
| 141 | * MP0001346_abnormal_lacrimal_gland | 0.51371353 |
| 142 | MP0004043_abnormal_pH_regulation | 0.51106654 |
| 143 | MP0000534_abnormal_ureter_morphology | 0.49989217 |
| 144 | MP0000266_abnormal_heart_morphology | 0.49474819 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.49450642 |
| 146 | * MP0002734_abnormal_mechanical_nocicepti | 0.49268062 |
| 147 | MP0003632_abnormal_nervous_system | 0.49227464 |
| 148 | * MP0001943_abnormal_respiration | 0.48239609 |
| 149 | MP0003385_abnormal_body_wall | 0.45734283 |
| 150 | MP0003938_abnormal_ear_development | 0.43458780 |
| 151 | MP0002081_perinatal_lethality | 0.43209619 |
| 152 | MP0001879_abnormal_lymphatic_vessel | 0.42908835 |
| 153 | MP0004197_abnormal_fetal_growth/weight/ | 0.41054474 |
| 154 | MP0004133_heterotaxia | 0.39095153 |
| 155 | MP0009672_abnormal_birth_weight | 0.38344972 |
| 156 | MP0000631_abnormal_neuroendocrine_gland | 0.38070175 |
| 157 | MP0003948_abnormal_gas_homeostasis | 0.35586070 |
| 158 | MP0002938_white_spotting | 0.35465832 |
| 159 | MP0003755_abnormal_palate_morphology | 0.34835557 |
| 160 | MP0002160_abnormal_reproductive_system | 0.34133095 |
| 161 | MP0002116_abnormal_craniofacial_bone | 0.33231825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myopathic facies (HP:0002058) | 6.47684646 |
| 2 | Limb dystonia (HP:0002451) | 4.93081408 |
| 3 | Ulnar deviation of the wrist (HP:0003049) | 4.86231467 |
| 4 | Calcaneovalgus deformity (HP:0001848) | 4.66912882 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.59559953 |
| 6 | Aplasia of the musculature (HP:0100854) | 4.43268696 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.38425342 |
| 8 | Amblyopia (HP:0000646) | 4.30308543 |
| 9 | Deformed tarsal bones (HP:0008119) | 4.11827173 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.10253824 |
| 11 | Congenital cataract (HP:0000519) | 4.03314783 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.02693121 |
| 13 | Neck muscle weakness (HP:0000467) | 3.95498023 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.91864333 |
| 15 | Xanthomatosis (HP:0000991) | 3.87331926 |
| 16 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.82512628 |
| 17 | Subaortic stenosis (HP:0001682) | 3.77173310 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.77173310 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.74360969 |
| 20 | Complement deficiency (HP:0004431) | 3.70702946 |
| 21 | Muscle fiber inclusion bodies (HP:0100299) | 3.60896594 |
| 22 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.60147257 |
| 23 | Rimmed vacuoles (HP:0003805) | 3.44264989 |
| 24 | Increased connective tissue (HP:0009025) | 3.39740375 |
| 25 | Absent phalangeal crease (HP:0006109) | 3.38533514 |
| 26 | Abnormality of placental membranes (HP:0011409) | 3.30045820 |
| 27 | Amniotic constriction ring (HP:0009775) | 3.30045820 |
| 28 | Nemaline bodies (HP:0003798) | 3.29034509 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.25703176 |
| 30 | Fatigable weakness (HP:0003473) | 3.20230597 |
| 31 | Abnormality of the neuromuscular junction (HP:0003398) | 3.20230597 |
| 32 | Epidermoid cyst (HP:0200040) | 3.13041811 |
| 33 | Weak cry (HP:0001612) | 3.12750236 |
| 34 | Myotonia (HP:0002486) | 3.12312229 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 3.11956733 |
| 36 | Muscle stiffness (HP:0003552) | 3.11221181 |
| 37 | Corneal dystrophy (HP:0001131) | 3.08033526 |
| 38 | Fetal akinesia sequence (HP:0001989) | 3.06458991 |
| 39 | Slender build (HP:0001533) | 2.98564149 |
| 40 | Asymmetric septal hypertrophy (HP:0001670) | 2.97780308 |
| 41 | Hypolipoproteinemia (HP:0010981) | 2.97094457 |
| 42 | Abnormal finger flexion creases (HP:0006143) | 2.93163508 |
| 43 | Type 2 muscle fiber atrophy (HP:0003554) | 2.92156161 |
| 44 | Sudden death (HP:0001699) | 2.91414226 |
| 45 | Abnormal pupillary function (HP:0007686) | 2.87482163 |
| 46 | Bulbar palsy (HP:0001283) | 2.86270649 |
| 47 | Ketosis (HP:0001946) | 2.84917258 |
| 48 | Frequent falls (HP:0002359) | 2.83920435 |
| 49 | Generalized muscle weakness (HP:0003324) | 2.83679678 |
| 50 | Muscle fiber atrophy (HP:0100295) | 2.82389002 |
| 51 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.79240872 |
| 52 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.78914088 |
| 53 | Gowers sign (HP:0003391) | 2.78098227 |
| 54 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.76969194 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.72845959 |
| 56 | Joint hemorrhage (HP:0005261) | 2.72398282 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.71100724 |
| 58 | Exercise-induced myalgia (HP:0003738) | 2.69187216 |
| 59 | Abnormality of the calcaneus (HP:0008364) | 2.67894859 |
| 60 | Abnormality of complement system (HP:0005339) | 2.66343911 |
| 61 | Progressive muscle weakness (HP:0003323) | 2.65641727 |
| 62 | Fat malabsorption (HP:0002630) | 2.59097638 |
| 63 | Calf muscle hypertrophy (HP:0008981) | 2.53936990 |
| 64 | Hyperglycinemia (HP:0002154) | 2.52830000 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.52370160 |
| 66 | Areflexia of lower limbs (HP:0002522) | 2.48301978 |
| 67 | Hyperammonemia (HP:0001987) | 2.46212030 |
| 68 | EMG: neuropathic changes (HP:0003445) | 2.45301639 |
| 69 | Hypoalphalipoproteinemia (HP:0003233) | 2.44816994 |
| 70 | Limb-girdle muscle atrophy (HP:0003797) | 2.44237971 |
| 71 | Type 1 muscle fiber predominance (HP:0003803) | 2.42105730 |
| 72 | Hip contracture (HP:0003273) | 2.40520351 |
| 73 | Distal arthrogryposis (HP:0005684) | 2.40409272 |
| 74 | Popliteal pterygium (HP:0009756) | 2.36791202 |
| 75 | Cerebral edema (HP:0002181) | 2.35183671 |
| 76 | Malignant hyperthermia (HP:0002047) | 2.34840050 |
| 77 | Hyporeflexia of lower limbs (HP:0002600) | 2.33572790 |
| 78 | Akinesia (HP:0002304) | 2.31088878 |
| 79 | Skin nodule (HP:0200036) | 2.27870234 |
| 80 | Muscle fiber splitting (HP:0003555) | 2.27868028 |
| 81 | Bundle branch block (HP:0011710) | 2.27123431 |
| 82 | Hypothermia (HP:0002045) | 2.27104000 |
| 83 | Scapular winging (HP:0003691) | 2.24466711 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 2.23803212 |
| 85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.23803212 |
| 86 | Distal lower limb amyotrophy (HP:0008944) | 2.23795784 |
| 87 | Hyperglycinuria (HP:0003108) | 2.22277394 |
| 88 | Round ear (HP:0100830) | 2.19586573 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 2.18437922 |
| 90 | Cholecystitis (HP:0001082) | 2.18437922 |
| 91 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.17803538 |
| 92 | Dilated cardiomyopathy (HP:0001644) | 2.16864196 |
| 93 | Short palpebral fissure (HP:0012745) | 2.12660199 |
| 94 | Difficulty running (HP:0009046) | 2.12258019 |
| 95 | Ragged-red muscle fibers (HP:0003200) | 2.11982145 |
| 96 | Increased intramyocellular lipid droplets (HP:0012240) | 2.09711060 |
| 97 | Shoulder girdle muscle weakness (HP:0003547) | 2.08702744 |
| 98 | Thin ribs (HP:0000883) | 2.07255523 |
| 99 | * Anterior segment dysgenesis (HP:0007700) | 2.06403454 |
| 100 | Abnormality of the common coagulation pathway (HP:0010990) | 2.05614393 |
| 101 | Spinal rigidity (HP:0003306) | 2.04887921 |
| 102 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.04094313 |
| 103 | Glomerulonephritis (HP:0000099) | 2.03925002 |
| 104 | Myoglobinuria (HP:0002913) | 2.02912864 |
| 105 | Rhabdomyolysis (HP:0003201) | 2.00944096 |
| 106 | Ketoacidosis (HP:0001993) | 2.00831051 |
| 107 | Nuclear cataract (HP:0100018) | 13.1026963 |
| 108 | Zonular cataract (HP:0010920) | 11.4144088 |
| 109 | Ventricular tachycardia (HP:0004756) | 1.97603821 |
| 110 | Lipoatrophy (HP:0100578) | 1.94558933 |
| 111 | Exercise-induced muscle cramps (HP:0003710) | 1.94104219 |
| 112 | Acute encephalopathy (HP:0006846) | 1.91781923 |
| 113 | Waddling gait (HP:0002515) | 1.89527885 |
| 114 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.88975158 |
| 115 | Poor suck (HP:0002033) | 1.87944664 |
| 116 | Cortical dysplasia (HP:0002539) | 1.87545736 |
| 117 | * Polar cataract (HP:0010696) | 1.85767116 |
| 118 | Nonprogressive disorder (HP:0003680) | 1.85400588 |
| 119 | Neonatal onset (HP:0003623) | 1.83410835 |
| 120 | Easy fatigability (HP:0003388) | 1.82554022 |
| 121 | Long clavicles (HP:0000890) | 1.81759759 |
| 122 | Increased muscle lipid content (HP:0009058) | 1.81195135 |
| 123 | Microcornea (HP:0000482) | 1.80676896 |
| 124 | Morphological abnormality of the middle ear (HP:0008609) | 1.80145332 |
| 125 | Abnormality of the intrinsic pathway (HP:0010989) | 1.79405675 |
| 126 | Exercise intolerance (HP:0003546) | 1.78973291 |
| 127 | Metatarsus adductus (HP:0001840) | 1.77828704 |
| 128 | Wrist flexion contracture (HP:0001239) | 1.77507796 |
| 129 | Steatorrhea (HP:0002570) | 1.77484421 |
| 130 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.76950117 |
| 131 | Abnormality of the calf musculature (HP:0001430) | 1.76626717 |
| 132 | Hypercholesterolemia (HP:0003124) | 1.75714254 |
| 133 | EMG: myopathic abnormalities (HP:0003458) | 1.74914440 |
| 134 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.74640512 |
| 135 | Hyperkalemia (HP:0002153) | 1.74051460 |
| 136 | Abnormality of the Achilles tendon (HP:0005109) | 1.73363913 |
| 137 | Gout (HP:0001997) | 1.72533747 |
| 138 | Cerebral inclusion bodies (HP:0100314) | 1.72116590 |
| 139 | Hypoplastic heart (HP:0001961) | 1.72059365 |
| 140 | Abnormality of the axillary hair (HP:0100134) | 1.71550064 |
| 141 | Abnormality of secondary sexual hair (HP:0009888) | 1.71550064 |
| 142 | Pterygium (HP:0001059) | 1.71521281 |
| 143 | Pelvic girdle muscle weakness (HP:0003749) | 1.71148202 |
| 144 | Abnormality of the foot musculature (HP:0001436) | 1.71066514 |
| 145 | Abnormal gallbladder morphology (HP:0012437) | 1.70626692 |
| 146 | Difficulty climbing stairs (HP:0003551) | 1.70509424 |
| 147 | Visual hallucinations (HP:0002367) | 1.70402647 |
| 148 | Lipid accumulation in hepatocytes (HP:0006561) | 1.70122207 |
| 149 | Cholelithiasis (HP:0001081) | 1.69744232 |
| 150 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68738768 |
| 151 | Late onset (HP:0003584) | 1.67645460 |
| 152 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.66730448 |
| 153 | Proximal amyotrophy (HP:0007126) | 1.66462561 |
| 154 | Acute necrotizing encephalopathy (HP:0006965) | 1.65772458 |
| 155 | Adducted thumb (HP:0001181) | 1.64279348 |
| 156 | Diminished movement (HP:0002374) | 1.63469129 |
| 157 | Concave nail (HP:0001598) | 1.62857493 |
| 158 | Abnormality of the parathyroid morphology (HP:0011766) | 1.61709650 |
| 159 | Lethargy (HP:0001254) | 1.60217609 |
| 160 | Ulnar deviation of finger (HP:0009465) | 1.57634350 |
| 161 | Heart block (HP:0012722) | 1.56524609 |
| 162 | Lower limb amyotrophy (HP:0007210) | 1.56245347 |
| 163 | Limb-girdle muscle weakness (HP:0003325) | 1.56095464 |
| 164 | Foot dorsiflexor weakness (HP:0009027) | 1.55025318 |
| 165 | Muscular dystrophy (HP:0003560) | 1.52934954 |
| 166 | Facial diplegia (HP:0001349) | 1.50647609 |
| 167 | Limited hip movement (HP:0008800) | 1.50333610 |
| 168 | Double outlet right ventricle (HP:0001719) | 1.49317254 |
| 169 | Congenital malformation of the right heart (HP:0011723) | 1.49317254 |
| 170 | Abnormal atrioventricular conduction (HP:0005150) | 1.48739298 |
| 171 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.42879938 |
| 172 | Generalized amyotrophy (HP:0003700) | 1.41240995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 3.10259233 |
| 2 | MARK1 | 3.06060790 |
| 3 | FGFR2 | 2.89342399 |
| 4 | GRK6 | 2.80772205 |
| 5 | CASK | 2.55381687 |
| 6 | PHKG1 | 2.43947667 |
| 7 | PHKG2 | 2.43947667 |
| 8 | CSNK1G3 | 2.40947428 |
| 9 | PNCK | 2.40903314 |
| 10 | OBSCN | 2.40387008 |
| 11 | MAP2K4 | 2.22398407 |
| 12 | IRAK2 | 2.19671902 |
| 13 | ERBB4 | 2.10637986 |
| 14 | CSNK1G1 | 2.04863105 |
| 15 | PIK3CG | 1.99104854 |
| 16 | CSNK1G2 | 1.90687243 |
| 17 | NTRK2 | 1.88694128 |
| 18 | GRK5 | 1.85205401 |
| 19 | MAPK13 | 1.82185530 |
| 20 | MAP2K3 | 1.79097110 |
| 21 | TYRO3 | 1.73494385 |
| 22 | SIK1 | 1.66260369 |
| 23 | EEF2K | 1.61846249 |
| 24 | LATS2 | 1.60085813 |
| 25 | TRIB3 | 1.56130123 |
| 26 | FGR | 1.49469093 |
| 27 | TTN | 1.46858298 |
| 28 | MAP2K6 | 1.42265469 |
| 29 | UHMK1 | 1.41883716 |
| 30 | LATS1 | 1.39415274 |
| 31 | MAPKAPK5 | 1.32446258 |
| 32 | PDGFRA | 1.29121289 |
| 33 | MINK1 | 1.28943586 |
| 34 | BCKDK | 1.28585838 |
| 35 | CCNB1 | 1.26668758 |
| 36 | MAP3K10 | 1.24561416 |
| 37 | PAK6 | 1.24405806 |
| 38 | PAK3 | 1.23727730 |
| 39 | MOS | 1.18099626 |
| 40 | NME1 | 1.17103784 |
| 41 | DYRK2 | 1.09494068 |
| 42 | MAPK12 | 1.07686176 |
| 43 | MAP3K12 | 1.06715716 |
| 44 | DYRK1B | 1.05638443 |
| 45 | NEK1 | 1.03121921 |
| 46 | MAP2K1 | 1.01998858 |
| 47 | PKN1 | 0.97145610 |
| 48 | BCR | 0.96413265 |
| 49 | CSNK1A1L | 0.96021343 |
| 50 | RIPK1 | 0.95881747 |
| 51 | PDK2 | 0.95839711 |
| 52 | RET | 0.95653541 |
| 53 | MAPK4 | 0.95205906 |
| 54 | FGFR1 | 0.94704775 |
| 55 | MAP3K4 | 0.94192809 |
| 56 | CDK8 | 0.87172975 |
| 57 | DDR2 | 0.86771615 |
| 58 | ADRBK1 | 0.85058762 |
| 59 | ERN1 | 0.83846398 |
| 60 | CDK18 | 0.83697773 |
| 61 | CDK15 | 0.82634178 |
| 62 | PTK2 | 0.80571166 |
| 63 | MAP2K7 | 0.79317995 |
| 64 | PLK2 | 0.77842326 |
| 65 | PTK2B | 0.76482722 |
| 66 | DYRK1A | 0.76353484 |
| 67 | PTK6 | 0.75173872 |
| 68 | LIMK1 | 0.74757116 |
| 69 | CAMK1G | 0.73092395 |
| 70 | PINK1 | 0.72128129 |
| 71 | KSR1 | 0.71505039 |
| 72 | INSRR | 0.71125488 |
| 73 | ERBB3 | 0.69366394 |
| 74 | MST1R | 0.69356964 |
| 75 | FER | 0.69190608 |
| 76 | CDK11A | 0.69058282 |
| 77 | PRKCQ | 0.67899076 |
| 78 | WEE1 | 0.67488827 |
| 79 | CDK14 | 0.67426079 |
| 80 | CAMK2A | 0.65508048 |
| 81 | CAMK2B | 0.65203839 |
| 82 | ICK | 0.64341439 |
| 83 | CDK5 | 0.64260613 |
| 84 | YES1 | 0.64198590 |
| 85 | TRPM7 | 0.63667029 |
| 86 | KSR2 | 0.63343159 |
| 87 | CDK12 | 0.63219600 |
| 88 | BUB1 | 0.63067898 |
| 89 | ERBB2 | 0.62842978 |
| 90 | BLK | 0.58824472 |
| 91 | PRKG1 | 0.58794797 |
| 92 | CAMK2G | 0.57885525 |
| 93 | AKT2 | 0.57787856 |
| 94 | CDK7 | 0.57719060 |
| 95 | CAMK4 | 0.57609490 |
| 96 | BRAF | 0.56393898 |
| 97 | CDK19 | 0.56171626 |
| 98 | PKN2 | 0.55254507 |
| 99 | STK39 | 0.54917789 |
| 100 | MAP3K7 | 0.54240487 |
| 101 | SGK1 | 0.53519996 |
| 102 | MAPK15 | 0.53262784 |
| 103 | ABL2 | 0.52960377 |
| 104 | PRKACG | 0.52183740 |
| 105 | EPHB2 | 0.51066038 |
| 106 | MAPK11 | 0.50870142 |
| 107 | MUSK | 0.50364461 |
| 108 | CAMK2D | 0.50292190 |
| 109 | PRKACB | 0.49443931 |
| 110 | DYRK3 | 0.48425903 |
| 111 | MAPKAPK3 | 0.47812320 |
| 112 | PRKAA2 | 0.47653214 |
| 113 | PRKCB | 0.47526575 |
| 114 | TAOK2 | 0.46052746 |
| 115 | WNK4 | 0.45899289 |
| 116 | DMPK | 0.45412294 |
| 117 | PRKAA1 | 0.44663527 |
| 118 | CSNK1E | 0.44238896 |
| 119 | PRKCG | 0.42051014 |
| 120 | MAPK10 | 0.40644504 |
| 121 | STK11 | 0.40389717 |
| 122 | VRK2 | 0.40040171 |
| 123 | PRKACA | 0.39822347 |
| 124 | CHEK2 | 0.38558391 |
| 125 | NEK9 | 0.38043000 |
| 126 | ILK | 0.36605789 |
| 127 | CDC7 | 0.35087033 |
| 128 | MAPK7 | 0.29070884 |
| 129 | RPS6KB2 | 0.28335395 |
| 130 | MTOR | 0.21261523 |
| 131 | CDK1 | 0.19842430 |
| 132 | RPS6KA3 | 0.19497893 |
| 133 | AURKA | 0.18739552 |
| 134 | IRAK3 | 0.18517784 |
| 135 | ROCK1 | 0.18329237 |
| 136 | RPS6KA1 | 0.17349633 |
| 137 | CDK2 | 0.17170399 |
| 138 | PRKCI | 0.16797227 |
| 139 | MAP3K1 | 0.15765367 |
| 140 | RPS6KA6 | 0.15683676 |
| 141 | MAPK14 | 0.15527938 |
| 142 | GSK3B | 0.15364376 |
| 143 | PAK1 | 0.14854530 |
| 144 | PDPK1 | 0.14450127 |
| 145 | LRRK2 | 0.14304170 |
| 146 | CDK4 | 0.12804898 |
| 147 | MAPK9 | 0.12767087 |
| 148 | TESK1 | 0.12255427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50125472 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45675452 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31194605 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05813025 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 3.00725787 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61605125 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31398840 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.31378627 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31366231 |
| 10 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.29821879 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25409252 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.22367957 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21131470 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.11046623 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.10957403 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07593172 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92209672 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.87138462 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86438445 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76404696 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.75363485 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.74849748 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.67262940 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58107260 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.55072779 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54943682 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.44430833 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41494928 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40936627 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40721710 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.40083025 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.39922780 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39658537 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38267803 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.37621977 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33885771 |
| 37 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.30614522 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24268664 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.22754767 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22120262 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21682703 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19224131 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18188680 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17228473 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.16793428 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16673658 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12881330 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10533086 |
| 49 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02090999 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01985371 |
| 51 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01594733 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00794673 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99162244 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99046350 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98943889 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93775741 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92291845 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.91399846 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.91114204 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86537534 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85689611 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84634466 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.84420488 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.80220944 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79564323 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79346495 |
| 67 | Nicotine addiction_Homo sapiens_hsa05033 | 0.70419059 |
| 68 | Glioma_Homo sapiens_hsa05214 | 0.69845256 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.68758636 |
| 70 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68188365 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67276135 |
| 72 | Melanoma_Homo sapiens_hsa05218 | 0.66305499 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65330586 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.64093933 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60967437 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59183279 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58554024 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58119889 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.57189396 |
| 80 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54886368 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53353740 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51989098 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51592011 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51580988 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.49118378 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48809595 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47882193 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46830824 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46333491 |
| 90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.44795540 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44429200 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.41572678 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41321952 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.41005049 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40853541 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40751406 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39949947 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39550692 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39044387 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.39027635 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38844698 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37463797 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37169696 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36955649 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.36087424 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35962293 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35853608 |
| 108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35522952 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33640614 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33241402 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31773247 |
| 112 | Axon guidance_Homo sapiens_hsa04360 | 0.31598274 |
| 113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.30025977 |
| 114 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29971978 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29926141 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29622531 |
| 117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.28738809 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27644803 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.27007683 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26923288 |
| 121 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26757842 |
| 122 | Cell cycle_Homo sapiens_hsa04110 | 0.26716272 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26158256 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25825560 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.25595767 |
| 126 | RNA polymerase_Homo sapiens_hsa03020 | 0.25343453 |
| 127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25320967 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25183260 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24548172 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24199364 |
| 131 | Olfactory transduction_Homo sapiens_hsa04740 | 0.24082543 |
| 132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23742708 |
| 133 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23173081 |
| 134 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21890747 |
| 135 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21729101 |
| 136 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.17653362 |
| 137 | Long-term depression_Homo sapiens_hsa04730 | 0.17509179 |
| 138 | Ribosome_Homo sapiens_hsa03010 | 0.16016375 |
| 139 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.14897866 |
| 140 | Melanogenesis_Homo sapiens_hsa04916 | 0.14830906 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.14662251 |
| 142 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.14484791 |

